Rachel Guanwei
Tao
Board of Advisor at Oculogyx.ai
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
Fri May 15 - 4:20 PM EDT/New York (See in local time)
Add to Calendar
05/15/2026 4:20 PM
05/15/2026 04:30 PM
America/New_York
#WTGC2026
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
#WTGC2026
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
https://www.womentech.net/ringcentral
https://www.womentech.net/ringcentral
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
"Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage"
Don’t miss out and join visionaries, innovators, and thought leaders from all over the world at the Women in Tech Global Conference.
Vote by Sharing
Unite 100 000 Women in Tech to Drive Change with Purpose and Impact.
Do you want to see this session? Help increase the sharing count and the session visibility. Sessions with +10 votes will be available to career ticket holders.
Please note that it might take some time until your share & vote is reflected.
Session: Innovation Is Easy. Adoption Is Hard: Why Product–Market Fit Is the Real AI Advantage
Artificial intelligence has dramatically lowered the barrier to building products. With today’s tools, it is easier than ever to create something technically impressive. Yet paradoxically, it has never been harder to achieve true product–market fit, sustained adoption, and successful commercialization.In this talk, I explore the growing gap between innovation and adoption—and why adoption, not invention, has become the real competitive advantage in the AI era. Drawing from my perspective as a Board Advisor to Oculogyx and years of product and commercialization experience, I will share how leaders and advisors evaluate whether an AI product will be trusted, adopted, and embedded into real-world workflows.
We will examine why even category-defining platforms must continuously evolve to keep pace with user expectations, and why technical capability alone does not guarantee market success. In regulated and high-trust environments such as healthcare, adoption challenges are amplified—making leadership judgment, product clarity, and workflow alignment essential.
Attendees will leave with a clearer understanding of how to think beyond “building the product” toward guiding AI solutions to real impact—by focusing on product–market fit, user behavior, and responsible commercialization. This session is especially relevant for product leaders, advisors, and women in tech who want to influence innovation without needing to be founders or engineers.
Key Takeaways
- Understand why innovation is no longer the hardest part of AI—and why adoption, product–market fit, and commercialization now determine success.
- Learn how leaders and advisors evaluate adoption readiness, including workflow fit, trust, usability, and value clarity, especially in regulated industries like healthcare.
- Identify common reasons AI products fail after launch, even when the technology is strong, and how to avoid these pitfalls early.
- Gain a practical framework for bridging innovation and adoption, helping teams move from “building the product” to achieving sustained real-world use.
- Recognize how strategic leadership—not just engineering or founding—shapes AI impact, offering a path for senior women to influence innovation through product and advisory roles.
Bio
Rachel Tao is a senior product and commercialization leader and a Board Advisor to Oculogyx, where she provides strategic guidance on innovation, AI adoption, product–market fit, and responsible commercialization in healthcare. With extensive experience across medical devices, digital health, and AI-enabled products, she focuses on guiding innovation toward solutions that are trusted, adopted, and sustained in real-world clinical workflows.